Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for NASDAQ stock CRSP Crispr Therapeutics. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 48.52 and Closed at: 49.70, which is 1.85% of previous session's close. It moved within a range of 47.37 and 49.83
The session was a Bullish session with an average volume of 1409200, which is 37.57% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 9 days back on short term averages
A Dead cross was found 8 days back on mid term averages
A Dead cross was found 2 days back on long term averages
Support for tomorrow is 48.54 and resistance for tomorrow is 51
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 48.1, 46.51 resistance for tomorrow's hourly charts is 50.56, 51.43
10 Day SMA for Crispr Therapeutics (CRSP) is 50.91 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 53.17 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 54.61 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 58.52 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 53.61 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 53.17 and 200 DMA is at 53.61, while 50 DMA and 100 DMA are at 54.61 and 58.52 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 53.17 and 20 EMA is at 52.26
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Mon Feb | 49.70 | 53.17 | 52.26 |
| 06 Fri Feb | 48.78 | 53.38 | 52.53 |
| 05 Thu Feb | 45.88 | 53.76 | 52.93 |
| 04 Wed Feb | 50.17 | 54.37 | 53.67 |
| 03 Tue Feb | 52.00 | 54.77 | 54.04 |
| 02 Mon Feb | 51.32 | 54.92 | 54.26 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 54.61 and 50 EMA is at 54.37
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Mon Feb | 49.70 | 54.61 | 54.37 |
| 06 Fri Feb | 48.78 | 54.68 | 54.56 |
| 05 Thu Feb | 45.88 | 54.73 | 54.8 |
| 04 Wed Feb | 50.17 | 54.82 | 55.16 |
| 03 Tue Feb | 52.00 | 54.8 | 55.36 |
| 02 Mon Feb | 51.32 | 54.78 | 55.5 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 58.52 and 100 EMA is at 55.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Mon Feb | 49.70 | 58.52 | 55.32 |
| 06 Fri Feb | 48.78 | 58.63 | 55.43 |
| 05 Thu Feb | 45.88 | 58.72 | 55.56 |
| 04 Wed Feb | 50.17 | 58.83 | 55.76 |
| 03 Tue Feb | 52.00 | 58.88 | 55.87 |
| 02 Mon Feb | 51.32 | 58.88 | 55.95 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 53.61 and 200 EMA is at 54.15
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Mon Feb | 49.70 | 53.61 | 54.15 |
| 06 Fri Feb | 48.78 | 53.55 | 54.19 |
| 05 Thu Feb | 45.88 | 53.5 | 54.24 |
| 04 Wed Feb | 50.17 | 53.46 | 54.32 |
| 03 Tue Feb | 52.00 | 53.4 | 54.36 |
| 02 Mon Feb | 51.32 | 53.33 | 54.38 |
Crispr Therapeutics has performed better than Xoma Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Xencor Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Tandem Diabetes in short term. Holding Crispr Therapeutics could be a better choice for now!
Syndax Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 12.23% more returns!
Crispr Therapeutics has performed better than Surgery Partners in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Orthofix Medical in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Novocure in short term. Holding Crispr Therapeutics could be a better choice for now!
Nektar Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 5.78% more returns!
Medicinova Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Medicinova Inc, about 24.05% more returns!
Crispr Therapeutics has performed better than Mesoblast in short term. Holding Crispr Therapeutics could be a better choice for now!
Liquidia Technologies has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Liquidia Technologies, about 26.01% more returns!
Aldeyra Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 44.78% more returns!
Crispr Therapeutics has performed better than Alnylam Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Alphatec Holdings in short term. Holding Crispr Therapeutics could be a better choice for now!
Axsome Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 13.78% more returns!
Collegium Pharmaceutical has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 6.28% more returns!
Champions Oncology has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 6.77% more returns!
Crispr Therapeutics has performed better than Dariohealth Corp in short term. Holding Crispr Therapeutics could be a better choice for now!
Iterum Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Iterum Therapeutics, about 1.07% more returns!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.29 and Crispr Therapeutics CRSP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
